{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:22:24Z","timestamp":1791588144754,"version":"4.3.4"},"reference-count":41,"publisher":"American Society of Hematology","issue":"2","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,8]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Telomere length shortening has been associated with genomic instability and acquisition of molecular lesions, but these processes have not been systematically studied across large cohorts of myeloid neoplasia (MN). As proof of concept for a novel, cross-validated whole-genome sequencing\u2013based method of telomere content (TC) determination combined with mutations, transcriptomics, and functional assays, we studied TC in correlation with specific molecular features of a large cohort (N = 1804) of patients with MN, including acute myeloid leukemia (AML) and myelodysplastic syndrome. When compared with healthy participants and patients with nonclonal diseases such as persistent polyclonal B-cell lymphocytosis, both MN and nonmalignant controls with clonal disease, such as paroxysmal nocturnal hemoglobinuria and aplastic anemia, exhibited decreased TC. Furthermore, we show that TC is lowered in adult MN abrogating correlation with age with considerable TC diversification among certain morphologic and molecular subtypes. For instance, AML harbored the lowest TC. Furthermore, MN originating from a more mature cell of origin (eg, acute promyelocytic leukemia) or characterized by hyperproliferative driver mutations (eg, RAS pathway genes) had lower TC, possibly indicating a loss of telomere maintenance capacity. In contrast, compared with other mutations, MN subtypes arising in a context of profound genetic alterations, such as TP53 mutations and complex karyotype, exhibited a relatively higher\/preserved TC. This phenomenon did not involve alternative lengthening processes but was rather consistent with an increased TC due to preserved activity of the telomerase complex. Our results describe a common and genotype-specific telomeric makeup of a large cohort of patients with MN providing a molecular benchmark for future therapeutic targeting of the telomere machinery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025028644","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:55:46Z","timestamp":1758578146000},"page":"197-208","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["Telomere content and genomics of myeloid neoplasia by whole-genome sequencing"],"prefix":"10.1182","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8293-0663","authenticated-orcid":false,"given":"Luca","family":"Guarnera","sequence":"first","affiliation":[{"name":"1Translational Hematology & Oncology Research, Cleveland Clinic, Cleveland, OH"},{"name":"2Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Wahida","sequence":"additional","affiliation":[{"name":"3Institute of Metabolism and Cell Death, Helmholtz Zentrum M\u00fcnchen, Neuherberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-5544","authenticated-orcid":false,"given":"Carmelo","family":"Gurnari","sequence":"additional","affiliation":[{"name":"1Translational Hematology & Oncology Research, Cleveland Clinic, Cleveland, OH"},{"name":"2Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2432-8898","authenticated-orcid":false,"given":"Stephan","family":"Hutter","sequence":"additional","affiliation":[{"name":"4Munich Leukemia Laboratory, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3746-7010","authenticated-orcid":false,"given":"Sabine A.","family":"Stainczyk","sequence":"additional","affiliation":[{"name":"5Hopp Children\u2019s Cancer Center, Heidelberg, Germany"},{"name":"6Division of Neuroblastoma Genomics, German Cancer Research Center, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8279-6476","authenticated-orcid":false,"given":"Nakisha D.","family":"Williams","sequence":"additional","affiliation":[{"name":"1Translational Hematology & Oncology Research, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arda","family":"Durmaz","sequence":"additional","affiliation":[{"name":"1Translational Hematology & Oncology Research, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7909-5422","authenticated-orcid":false,"given":"Yasuo","family":"Kubota","sequence":"additional","affiliation":[{"name":"1Translational Hematology & Oncology Research, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9794-7847","authenticated-orcid":false,"given":"Carlos","family":"Bravo-Perez","sequence":"additional","affiliation":[{"name":"1Translational Hematology & Oncology Research, Cleveland Clinic, Cleveland, OH"},{"name":"7Department of Hematology, Hospital Universitario Morales Meseguer, University of Murcia, Instituto Murciano de Investigaci\u00f3n Biosanitaria\u2013Pascual Parrilla, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras\u2013Instituto de Salud Carlos III, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9914-739X","authenticated-orcid":false,"given":"Naomi","family":"Kawashima","sequence":"additional","affiliation":[{"name":"1Translational Hematology & Oncology Research, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1842-6187","authenticated-orcid":false,"given":"Mark","family":"Orland","sequence":"additional","affiliation":[{"name":"1Translational Hematology & Oncology Research, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4688-2478","authenticated-orcid":false,"given":"Simona","family":"Pagliuca","sequence":"additional","affiliation":[{"name":"1Translational Hematology & Oncology Research, Cleveland Clinic, Cleveland, OH"},{"name":"8Hematology Department, Nancy University Hospital, Vandoeuvre-l\u00e8s-Nancy, France"},{"name":"9Universit\u00e9 de Lorraine, Centre National de la Recherche Scientifique, Unit\u00e9 Mixte de Recherche 7365, Ing\u00e9nierie Mol\u00e9culaire et Physiopathologie Articulaire, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Huang","sequence":"additional","affiliation":[{"name":"10Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"LaFramboise","sequence":"additional","affiliation":[{"name":"10Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2993-1509","authenticated-orcid":false,"given":"Valeria","family":"Visconte","sequence":"additional","affiliation":[{"name":"1Translational Hematology & Oncology Research, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5083-9838","authenticated-orcid":false,"given":"Wencke","family":"Walter","sequence":"additional","affiliation":[{"name":"4Munich Leukemia Laboratory, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manja","family":"Meggendorfer","sequence":"additional","affiliation":[{"name":"4Munich Leukemia Laboratory, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Kern","sequence":"additional","affiliation":[{"name":"4Munich Leukemia Laboratory, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1584-3636","authenticated-orcid":false,"given":"Frank","family":"Westermann","sequence":"additional","affiliation":[{"name":"5Hopp Children\u2019s Cancer Center, Heidelberg, Germany"},{"name":"6Division of Neuroblastoma Genomics, German Cancer Research Center, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1503-437X","authenticated-orcid":false,"given":"Lars","family":"Feuerbach","sequence":"additional","affiliation":[{"name":"11Division of Applied Bioinformatics, German Cancer Research Center, German Cancer Consortium, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[{"name":"4Munich Leukemia Laboratory, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6837-4346","authenticated-orcid":false,"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[{"name":"1Translational Hematology & Oncology Research, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2026010811220589400_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41467-019-13824-9","article-title":"Genomic footprints of activated telomere maintenance mechanisms in cancer","volume":"11","author":"Sieverling","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"2026010811220589400_bib2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood-2002-07-2334","article-title":"Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation","volume":"102","author":"Allsopp","year":"2003","journal-title":"Blood"},{"issue":"18","key":"2026010811220589400_bib3","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1182\/blood-2014-05-526285","article-title":"Bone marrow failure and the telomeropathies","volume":"124","author":"Townsley","year":"2014","journal-title":"Blood"},{"issue":"24","key":"2026010811220589400_bib4","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMra0903373","article-title":"Telomere diseases","volume":"361","author":"Calado","year":"2009","journal-title":"N Engl J Med"},{"issue":"8","key":"2026010811220589400_bib5","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.cell.2022.03.025","article-title":"Cancer stem cells: the adventurous journey from hematopoietic to leukemic stem cells","volume":"185","author":"Trumpp","year":"2022","journal-title":"Cell"},{"issue":"23","key":"2026010811220589400_bib6","article-title":"Microenvironment in acute myeloid leukemia: focus on senescence mechanisms, therapeutic interactions, and future directions","volume":"129","author":"Guarnera","year":"2024","journal-title":"Exp Hematol"},{"issue":"4","key":"2026010811220589400_bib7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/leu.2011.272","article-title":"Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia","volume":"26","author":"Calado","year":"2012","journal-title":"Leukemia"},{"issue":"26","key":"2026010811220589400_bib8","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1182\/blood.2020005397","article-title":"Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome","volume":"136","author":"Myllym\u00e4ki","year":"2020","journal-title":"Blood"},{"issue":"10","key":"2026010811220589400_bib9","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1182\/blood.2021011075","article-title":"The clinical and functional effects of TERT variants in myelodysplastic syndrome","volume":"138","author":"Reilly","year":"2021","journal-title":"Blood"},{"issue":"4","key":"2026010811220589400_bib10","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/hon.2967","article-title":"A study of telomerase reverse transcriptase rare variants in myeloid neoplasia","volume":"40","author":"Gurnari","year":"2022","journal-title":"Hematol Oncol"},{"issue":"9","key":"2026010811220589400_bib11","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/s41588-024-01884-7","article-title":"Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences","volume":"56","author":"Burren","year":"2024","journal-title":"Nat Genet"},{"issue":"23","key":"2026010811220589400_bib12","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1182\/blood.2024025023","article-title":"Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescuing and cancer mutations","volume":"144","author":"Gutierrez-Rodrigues","year":"2024","journal-title":"Blood"},{"issue":"10","key":"2026010811220589400_bib13","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa1310523","article-title":"A pilot study of the telomerase inhibitor imetelstat for myelofibrosis","volume":"373","author":"Tefferi","year":"2015","journal-title":"N Engl J Med"},{"issue":"10423","key":"2026010811220589400_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(23)01724-5","article-title":"Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"403","author":"Platzbecker","year":"2024","journal-title":"Lancet"},{"issue":"9","key":"2026010811220589400_bib15","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/nprot.2010.124","article-title":"Measurement of telomere length by the southern blot analysis of terminal restriction fragment lengths","volume":"5","author":"Kimura","year":"2010","journal-title":"Nat Protoc"},{"key":"2026010811220589400_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.psyneuen.2018.10.005","article-title":"Telomere length measurement by qPCR - summary of critical factors and recommendations for assay design","volume":"99","author":"Lin","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"2026010811220589400_bib17","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/cyto.a.22982","article-title":"Telomere content measurement in human hematopoietic cells: comparative analysis of qPCR and flow-FISH techniques","volume":"89","author":"Wand","year":"2016","journal-title":"Cytometry A"},{"issue":"1","key":"2026010811220589400_bib18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12859-019-2851-0","article-title":"TelomereHunter - in silico estimation of telomere content and composition from cancer genomes","volume":"20","author":"Feuerbach","year":"2019","journal-title":"BMC Bioinformatics"},{"issue":"9","key":"2026010811220589400_bib19","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1093\/nar\/gku181","article-title":"Estimating telomere length from whole genome sequence data","volume":"42","author":"Ding","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"2026010811220589400_bib20","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"16","key":"2026010811220589400_bib21","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1093\/bioinformatics\/btt314","article-title":"Isaac: ultra-fast whole-genome secondary analysis on Illumina sequencing platforms","volume":"29","author":"Raczy","year":"2013","journal-title":"Bioinformatics"},{"issue":"5","key":"2026010811220589400_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2026010811220589400_bib23","doi-asserted-by":"crossref","first-page":"104059","DOI":"10.1016\/j.ebiom.2022.104059","article-title":"Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q","volume":"80","author":"Adema","year":"2022","journal-title":"EBioMedicine"},{"issue":"12","key":"2026010811220589400_bib24","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nbt.1587","article-title":"DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity","volume":"27","author":"Henson","year":"2009","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2026010811220589400_bib25","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s41375-020-1002-y","article-title":"Complex landscape of alternative splicing in myeloid neoplasms","volume":"35","author":"Hershberger","year":"2021","journal-title":"Leukemia"},{"issue":"5","key":"2026010811220589400_bib26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation","volume":"28","author":"Trapnell","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"6","key":"2026010811220589400_bib27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11899-023-00717-4","article-title":"Experimental and computational approaches to measure telomere length: recent advances and future directions","volume":"18","author":"Ferrer","year":"2023","journal-title":"Curr Hematol Malig Rep"},{"issue":"1","key":"2026010811220589400_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13045-023-01480-y","article-title":"Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia","volume":"16","author":"Bahaj","year":"2023","journal-title":"J Hematol Oncol"},{"issue":"3","key":"2026010811220589400_bib29","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3390\/cancers12030637","article-title":"Functional classification of TP53 mutations in acute myeloid leukemia","volume":"12","author":"Dutta","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2026010811220589400_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41467-020-20474-9","article-title":"Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation","volume":"12","author":"Noureen","year":"2021","journal-title":"Nat Commun"},{"issue":"6041","key":"2026010811220589400_bib31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1126\/science.1207313","article-title":"Altered telomeres in tumors with ATRX and DAXX mutations","volume":"333","author":"Heaphy","year":"2011","journal-title":"Science"},{"issue":"1","key":"2026010811220589400_bib32","first-page":"418","article-title":"Have we reached a molecular era in myelodysplastic syndromes?","volume":"2021","author":"Voso","year":"2021","journal-title":"Hematol Am Soc Hematol Educ Program 2021"},{"issue":"10","key":"2026010811220589400_bib33","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa2024534","article-title":"Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers","volume":"384","author":"Duncavage","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"2026010811220589400_bib34","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1182\/blood.2024025023","article-title":"Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations","volume":"144","author":"Gutierrez-Rodrigues","year":"2024","journal-title":"Blood"},{"issue":"14","key":"2026010811220589400_bib35","doi-asserted-by":"crossref","first-page":"eabl6579","DOI":"10.1126\/sciadv.abl6579","article-title":"Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential","volume":"8","author":"Nakao","year":"2022","journal-title":"Sci Adv"},{"issue":"16","key":"2026010811220589400_bib36","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1182\/bloodadvances.2023010156","article-title":"Genomic landscape of TP53-mutated myeloid malignancies","volume":"7","author":"Abel","year":"2023","journal-title":"Blood Adv"},{"issue":"1","key":"2026010811220589400_bib37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1200\/JCO.20.01895","article-title":"Imetelstat achieves meaningful and durable transfusion independence in high transfusion-burden patients with lower-risk myelodysplastic syndromes in a phase II study","volume":"39","author":"Steensma","year":"2021","journal-title":"J Clin Oncol"},{"issue":"1","key":"2026010811220589400_bib38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00277-021-04683-w","article-title":"Favorable overall survival with imetelstat in relapsed\/refractory myelofibrosis patients compared with real-world data","volume":"101","author":"Kuykendall","year":"2022","journal-title":"Ann Hematol"},{"issue":"10","key":"2026010811220589400_bib39","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1056\/NEJMoa1503479","article-title":"Telomerase inhibitor imetelstat in patients with essential thrombocythemia","volume":"373","author":"Baerlocher","year":"2015","journal-title":"N Engl J Med"},{"issue":"6684","key":"2026010811220589400_bib40","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1126\/science.adg3224","article-title":"ATR blocks telomerase from converting DNA breaks into telomeres","volume":"383","author":"Kinzig","year":"2024","journal-title":"Science"},{"issue":"7","key":"2026010811220589400_bib41","doi-asserted-by":"crossref","first-page":"100588","DOI":"10.1016\/j.xgen.2024.100588","article-title":"Neotelomeres and telomere-spanning chromosomal arm fusions in cancer genomes revealed by long-read sequencing","volume":"4","author":"Tan","year":"2024","journal-title":"Cell Genom"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/2\/197\/2478751\/blood_bld-2025-028644-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/2\/197\/2478751\/blood_bld-2025-028644-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:22:19Z","timestamp":1767889339000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/2\/197\/547407\/Telomere-content-and-genomics-of-myeloid-neoplasia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1,8]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025028644","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1,8]]},"published":{"date-parts":[[2026,1,8]]}}}